VRCA
Verrica Pharmaceuticals: A Year of Transformation
The fourth quarter and year-end 2025 corporate update conference call hosted by Verrica Pharmaceuticals provided a comprehensive overview of the company's achievements in commercial, clinical, and financial initiatives. Jayson Rieger, President and CEO, highlighted that 2025 will be remembered as the year Verrica fundamentally transformed its business, setting